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ABSTRACT: 
Localized amyloid deposits (tumoral amyloidosis or amyloidoma) are uncommon form of 
amyloidosis and nodular pulmonary amyloidomas are rarely found. This incidental finding 
can mimic a bronchopulmonary neoplasm and may occur secondarily to an infectious, 
inflammatory or lymphoproliferative disease. We report a case of a 62-year-old female with 
long-standing systemic lupus erythematosus (SLE) with low compliance who presented with 
radiologically-verified solitary pulmonary nodule. Work-up included positron emission 
tomography-computed tomography (PET-CT) scan which revealed hypermetabolic uptake of 
F-18 fluorodeoxyglucose (FDG) and lobectomy was performed. Staining of the tissue was 
positive for Congo red and was green birefringent under polarized light. 
Immunohistochemical methods excluded lymphoproliferative disease and confirmed 
amyloidoma. SLE was controled with antimalarials and glucocorticoids. Pulmonary 
amyloidoma should be considered in the differential diagnosis of solitary lung nodules.       
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Amyloidoma; Solitary lung nodule; Lung cancer; PET-CT imaging; Systemic Lupus 
Erythematosus.  
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INTRODUCTION: 
Amyloid is an insoluble form of protein that can be deposited in almost every solid organ 
including the kidneys, heart, and liver.  Solitary localized tumour-like amyloid deposits or 
amyloidomas, without systemic amyloidosis are uncommon (1).   
Pulmonary amyloidomas (PA) may manifest in several forms:  tracheobronchial, nodular 
(most common) or diffuse parenchymal and alveolar septal. Nodular parenchymal 
amyloidosis radiographically presents as a single or multiple peripheral pulmonary nodules 
that may be of various sizes and margin contours (2).  Nodules are usually found 
subpleurally, in the lower lobes, and may be bilateral. Cavities are seen in up to 20% of 
cases and calcification in 20-50% on CT scans (3).  PA may grow very slowly over years and 
the long-term prognosis is typically favourable.  Patients are often elderly and asymptomatic, 
although symptomatology is related to the location and size of the lesion(s).  PA is therefore 
frequently discovered incidentally on routine chest x-rays (2,3).  Due to the rarity of 
amyloidomas and the scarcity of controlled clinical trials, management decisions are 
regularly made on an individual empirical basis (1). In most cases involving nodules that do 
not produce space-occupying effects, no intervention is required except for “watchful waiting” 
and regular follow-ups. Local recurrence rates following surgical control of PA are reported to 
be negligible. 
The cause of nodular PA is still unknown.  It is hypothesized to result due to a reaction to 
chronic inflammatory conditions affecting the lung, such as connective tissue disorders, 
tuberculosis, or HIV infection (1).  Amyloidomas have also been associated with systemic 
lymphoproliferative disorders and plasma cell dyscrasias, primarily multiple myeloma, and 
lymphoplasmacytic lymphoma (4).  It is therefore imperative that appropriate diagnostic 
testing is carried out to exclude these conditions. The gold standard for diagnosis of PA is 
pathohistological verification of tissue biopsy (1,2,4).  Nodular PAs histologically appear as 
well-circumscribed consolidated masses of dense, amorphous eosinophilic material, 
frequently associated with inflammatory infiltrates of plasma cells, lymphocytes, and 
histiocytes, and may include a granulomatous reaction of giant multinucleated cells 
surrounding the amyloid deposits (4). Congo red staining gives a definitive diagnosis as the 
appearance of green birefringence under polarized light is a pathognomonic feature of 
amyloid (1).   
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CASE REPORT: 
We report a case of a 62-year-old female attorney with a history of cervical conization (due to 
HPV infection) and a tonsillectomy at 42 years of age. She gave birth to a healthy son and 
had no history of miscarriage. The patient did not consume any tobacco, alcohol or illicit 
drugs. Her family history was positive for autoimmune disease (a grandmother with 
rheumatoid arthritis who also had pulmonary tuberculosis), and malignancy (brother had 
Hodgkin's lymphoma).  
The patient was diagnosed in 1980 with systemic lupus erythematosus - SLE (leucopaenia, 
lymphopaenia, positive ANA and dsDNA, arthritis, oral aphthae) with no major organ 
involvement (no signs of lupus nephritis and no neuropsychiatric systemic lupus 
erythematosus). She was prescribed oral glucocorticoids and azathioprine and was  
 subsequently followed by a rheumatologist over the next several years. The patient had a 
low adherence and low compliance to treatment and often missed recommended visits.  She 
independently stopped taking the prescribed medications approximately 30 years ago for 
fear of known side-effects and opted for alternative treatments. 
Her initial respiratory complaints began with symptoms of lower respiratory tract infection 
including febrile illness (maximum axillary body temperature of 40*C), a productive cough 
with thick green sputum, headache, and general malaise. Chest x-ray (Figure 1) revealed a 
heterogeneous dense opacity of the right supradiaphragmatic region highly suggestive of 
right lower lobe pneumonia.  After the course of oral antibiotics (moxifloxacin), her cough 
remitted but febrile illness persisted. Follow-up chest x-ray was unchanged and the patient 
was given an additional course of amoxicillin-clavulanic acid combination and azithromycin. 
She remained febrile with new symptoms of pain and stiffness in the large joints diffusely 
without any visible signs of joint inflammation.   
The patient was admitted to the Infectology Unit where she underwent complete laboratory 
and diagnostic assessment (elevated acute phase reactants, ESR being unproportionally 
higher then CRP).  Transthoracic cardiac ultrasound excluded endocarditis, but a mild mitral 
and tricuspid regurgitation was noted.  Ultrasound of the abdomen was unremarkable. 
Spirometry results were within normal limits; however, carbon monoxide diffusion capacity 
was somewhat decreased (74.4%).  CT scan of the thorax raised suspicion of an early lung 
cancer given that a solitary nodule (1.5 cm in diameter) with slightly spiculated margins and 
microcalcifications, appearing sclerotic, was observed in the right supradiaphragmatic region 
at the border of the latero- and postero-basal segments of the right lower lobe in close 
association with the bronchovascular bundle.  The appearance of the nodular formation 
seemed to indicate an older scarring-type lesion and below it were tracks of scarred tissue.  
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Further work-up was continued at the Pulmonology Unit where on two separate occasions, 
fiberbronchoscopy was performed. Cytologic results of bronchoscopic samples revealed 
inflammatory elements as well as several groups of uniform cells suspected to be 
carcinomatous.  Microbiologic results of bronchoscopic and sputum samples tested negative 
for tuberculosis infection (direct smear and later on the culture).  Given these findings, PET-
CT scan with 18F-FDG uptake was recommended to rule out lung carcinoma although the 
tumour markers CYFRA 21-1 and NSE were negative.   
PET revealed pathological utilization of the glucose analog (SUV max 5.25) corresponding to 
the pulmonary lesion (2.2 x 2 cm)  on CT imaging that was consistent with metabolically 
active tissue with morphological characteristics of a possible neoplastic process (Figure 2). 
There were no signs of lymphadenopathy, clinically and radiographically.   
Due to suspected lung carcinoma, thoracotomy with tumour resection with diagnostic and 
therapeutic intent was performed.  Intraoperative tumour biopsy revealed extensive necrosis, 
erythrocytes, lymphocytes, few plasma cells, multinucleated giant cells, poorly ordered 
groups of cubic epithelial cells with atypia, and some elastic tissue.  Given these inconclusive 
findings for possible tumour cells, right lower lobectomy (16x11.5x8 cm) with resection of 
bronchopulmonary (1 cm diameter) and mediastinal (2 cm diameter) lymph nodes was 
performed.  Postoperative histological findings of the lobectomized lung tissue were 
unremarkable; that of the lymph nodes showed reactive changes predominantly of the sinus 
histiocytosis type and was determined to be reactive lymphadenitis.  The resected tumour-
like mass (2.5 cm diameter) had sharply defined borders that macroscopically extended to 
the pleura.  Histologically, the nodule was composed of large deposits of thick, amorphous 
eosinophilic material, partly surrounded by multinucleated giant cells of foreign body type, 
and partly by granulation tissue or fibroblastic stroma. The eosinophilic material stained 
positively for Congo red and was green birefringent under polarized light which is 
characteristic of AA amyloid.  Deposits of AA amyloid were also found around the bronchus 
in the area of resected margin (Figure 3).  Additional immunohistochemical staining methods 
(CD3, CD20, CD31, kappa and lamba light chains) excluded lymphoproliferative diseases.  
The diagnosis of systemic amyloidosis was ruled out after analyzing abdominal 
subcutaneous fat. The fat sample did not bind Congo red and there was no green 
birefringence under polarized light. 
 
The patient’s postoperative course involved a slow general recovery and normal healing of 
the wound.  She continued to have low grade fever without any effect of the given antibiotics.  
Repeated bronchoscopy and analysis did not produce a pathological substrate.   
Because her past history of systemic autoimmune disease the possibility of the relaps of SLE 
was suspected. She was referred to the Rheumatology unit where she presented with low 
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grade fever, fatigue and general malaise, pain in the hips and spine, as well as worsening of 
joint stiffness.  There were no mucocutaneous or ophthalmological changes.  A 
comprehensive reevaluation was undertaken. The tests came back positive for active SLE 
(lymphopaenia, high titer of ANA and dsDNA) with polyclonal hypergammaglobulinaemia 
without involvement of the kidneys and central nervous systems and without elements for 
antiphospholipid syndrome. The patient was started on an oral corticosteroid (0.5 mg/kg 
methylprednisolone) with gradual tapering and began antimalarial therapy (chloroquine 
phosphate) with prompt improvement of her general condition.  
At the follow-up period (20 months post-op) the patient was in a good overall state of health.  
There were no major complaints with respect to respiratory functioning except for a dry 
irritating cough on occasion.  Cardiac ultrasound showed a good ejection fraction (65%) with 
mild mitral regurgitation and mild to moderate diastolic dysfunction without signs of 
pulmonary hypertension.  Her last chest x-ray was stationary and no fresh 
pleurobronchopulmonary lesions, lymphadenopathy or skeletal changes were noted.  She 
remained on a minimal maintenance dose of methylprednisolone (4 mg) and antimalarial 
drug (chloroquine 250 mg) for SLE without any signs of local or systemic recurrence of 
amyloidosis.  
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DISCUSSION: 
SLE is thought to be a T helper type 2 (Th2) driven disease, making cytokines IL-4, IL-5, and 
IL-10 and their association with humoral immune response and antibody production very 
important part of the pathogenesis of the disease. T helper type 1 (Th1) and T helper 17 
(Th17) cells also play an important role in the SLE. Acute phase reactants ESR and CRP are 
elevated via different set of cytokines from Th1 and Th2 response. Active SLE should 
predominantly be driven by Th2 response and have accelerated ESR and low CRP unless 
there is a parallel infection or serositis occurring.  
In our case initial laboratory findings at Infectology unit included ESR of 86 mm/h (normal 
value <24 mm/h) and CRP of 21.7 mg/l (normal value <5 mg/l) and during the patients stay 
at the Pulmonology unit ESR was 72 mm/h and CRP 6.7 mg/l. Disproportionality of ESR and 
CRP raised the suspicion of something other than infection which was confirmed to be an 
active SLE. As a result of an infection serum amyloid A (SAA) acts similar to CRP.  
Although pulmonary manifestations of SLE are common, pulmonary amyloidosis is extremely 
rare (5). Accumulation of amyloid is more likely to be registered in untreated and 
undertreated patients. The described patient’s non-compliance and low adherence was seen 
in irregular follow-up visits and periods of not taking any SLE drugs, leaving the disease 
untreated. This led to the episodes of active systemic inflammation which probably 
contributed to the formation of the amyloid. The potential mechanisms include long-lasting 
periods of active inflammation and activation of different cell types, predominantly B-cells. 
Although AA amyloid is rare in SLE and more common in Familial Mediterranean fever (FMF) 
and rheumatoid arthritis such cases have been described in medical literature (6). The 
formation of amyloid in our case is more likely related to the periods of untreated SLE caused 
by the low compliance of the patient and not merely a coincidence. There was no definitive 
evidence the cellular infiltrate in the lung nodule (amyloid) could point to a local cause of 
inflammation and local SAA production. 
The case described also brought up the suspicion of the malignancy. In general, patients 
with SLE have increased risk of different malignancies, non-Hodgkin’s lymphoma (diffuse 
large B cell) being the most common (with standardized incidence ratio of 3.64) (7). 
Dysregulation of lymphocyte proliferation which is characteristic for SLE and some 
chromosomal abnormalities (translocations) may be the mechanism responsible for the 
development of lymphoma. It is uncertain whether the activity of the SLE or SLE 
immunosuppressive medications lead to the risk of the development of lymphoma (7).  
Similar cases of unknown focal lesions should prompt us to perform additional tests to 
distinguish benign and malignant etiology of the lesions. The most important clinical 
implication after reaching the final diagnosis (amyloid vrs. tumour) is the planning of different 
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treatment options on an individual basis bearing in mind each patient’s individual course of 
disease.    
Positron emission tomography (PET) using 18F- fluorodeoxyglucose (FDG) is a widely used 
diagnostic and staging modality to evaluate solitary pulmonary nodules suspected of being 
malignant. PET-CT imaging may therefore reduce inappropriate invasive diagnostic 
investigation and subsequent complications (8).   
Increased FDG activity has also been described in benign pulmonary nodules.  Such false-
positive FDG results have been demonstrated in cases of active granulomatous disease 
(tuberculosis, fungal infections such as histoplasmosis and aspergillosis, and sarcoidosis), 
and inflammatory processes in the lungs (rheumatoid nodules and interstitial lung disease) 
and elsewhere (osteoarthritis, vascular thromboses, and osteoporosis) (9).  The reason for 
uptake of 18F-FDG in noncancerous conditions is unclear, but what is evident is that FDG is 
not tumour specific.  It is hypothesized that benign lesions containing elevated 
concentrations of inflammatory cells (i.e., neutrophils and activated macrophages) have 
higher metabolic rates and therefore, greater glucose uptake (10).   
Metser et al. conducted a retrospective review of 1134 consecutive reports of PET-CT 
studies in proven or suspected malignancy of various organs and found benign FDG uptake 
in over 25% of the PET-CT studies, with 28.2% of noncancerous lesions having moderate to 
marked FDG uptake.  The most common cause for FDG avidity in benign lesions was 
inflammation (73.3%), both infectious and noninfectious, thus confirming the findings of 
multiple previous reports on FDG uptake in such lesions.  A plausible explanation for the 
increased uptake of FDG in inflammatory processes is that activated leucocytes 
(granulocytes, lymphocytes, and macrophages) have enhanced levels of glucose 
transporters and an increased affinity to deoxyglucose through various cytokines and growth 
factors (10). The exact cause for FDG avidity in PA has not yet been fully elucidated.  It is 
plausible that an inflammatory reaction by the amyloid lesion itself (i.e., presence of 
histiocytic infiltration) leads to increased FDG uptake.  
In conclusion, solitary PA secondary to systemic lupus erythematosus is exceptionally rare.  
The differential diagnosis of a radiologically observed nodule in the lower respiratory tract 
should include benign lesion such as amyloidoma in addition to malignancy such as 
bronchopulmonary carcinoma.  18F-FDG PET-CT scan is a helpful diagnostic tool to 
characterize indeterminate pulmonary nodules but its specificity is limited, resulting in false 
positives, such as in our patient.  Plasma cell dyscrasias are commonly associated with 
amyloidosis and must be ruled out in each instance.  Surgical resection as a means of local 
control may be indicated, as was the case here.  Long-term follow-up is recommended due 
to possible development of systemic disease and/or local recurrence.  However, the 
prognosis is favourable and recurrence rates are low.  This case highlights the importance of 
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histological evaluation of tissue biopsy to confirm the diagnosis of suspected malignancy in 
18F-FDG avid lesions on PET-CT.  The management and treatment of solitary pulmonary 
nodule, therefore, necessitates a personalized approach based on all relevant diagnostic 
results.  Further studies to determine the etiology of PA in SLE patients and the mechanism 
of false positive 18F-FDG uptake in PA on PET-CT scan are warranted.   
 
 
  
10 
 
FIGURE 1: 
 
Chest x-ray: 
a - a solitary pulmonary nodule (arrow) in the right lower lung lobe prior to tumour resection 
and  
b - follow-up radiograph post-surgery.  
 
FIGURE 2: 
 
F-18 FDG PET-CT scan with SUV max of 5.25 in the solitary pulmonary nodule indicating a 
hypermetabolic lesion highly suspicious of a pulmonary malignancy
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FIGURE 3: 
 
a - Lung parenchyma with sharply demarcated amyloid deposits and scant lymphoplasmacytic infiltrate mostly at the periphery of deposits. On 
the right side, bronchial wall is seen with amyloid deposits between surface epithelium and bronchial cartilage with metaplastic ossification. 
(Hematoxylin-eosin stain, objective x 1,67). 
b - Amyloid deposits within the airway wall with occasional foreign body giant cells  
and mild infiltration of chronic inflammatory cells. Inlet demonstrates characteristic  
apple-green birefringence of Congo red-stained amyloid under polarized light. (Hematoxylin-eosin, objective x5, inlet Congo red under polarized 
light, objective x 2,5). 
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